Table 2.
Trial | Population | Improvedsurvival |
Polishtrial | Post-myocardial infarction,ineligible for β blockers | Yes |
CHF-STAT | Congestive heart failure,asymptomatic ectopy | No |
EMIAT | Post-myocardial infarction,low ejection fraction | No |
CAMIAT | Post-myocardial infarction,asymptomatic ectopy | Yes |
CAMIAT, Canadian amiodarone myocardial infarction arrhythmia trial; CHF-STAT, congestive heart failure: survival trial of antiarrhythmic therapy; EMIAT, European myocardial infarct amiodarone trial.